Cargando…
Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
There is a growing interest in the role of glucagon in type 2 diabetes mellitus (T2DM). Glucagon and insulin regulate glucose and lipid metabolism. Metabolic syndrome is an important risk factor for cardiovascular disease in patients with T2DM. We investigated the association between glucagon to ins...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531641/ https://www.ncbi.nlm.nih.gov/pubmed/37762748 http://dx.doi.org/10.3390/jcm12185806 |
_version_ | 1785111767086530560 |
---|---|
author | Bang, Jisun Lee, Sang Ah Koh, Gwanpyo Yoo, Soyeon |
author_facet | Bang, Jisun Lee, Sang Ah Koh, Gwanpyo Yoo, Soyeon |
author_sort | Bang, Jisun |
collection | PubMed |
description | There is a growing interest in the role of glucagon in type 2 diabetes mellitus (T2DM). Glucagon and insulin regulate glucose and lipid metabolism. Metabolic syndrome is an important risk factor for cardiovascular disease in patients with T2DM. We investigated the association between glucagon to insulin ratio and metabolic syndrome in patients with T2DM. This is a cross-sectional study involving 317 people with type 2 diabetes. Glucagon and insulin levels were measured in a fasted state and 30 min after ingesting a standard mixed meal. The Criteria of the International Diabetes Federation defined metabolic syndrome. Two hundred nineteen (69%) of the subjects had metabolic syndrome. The fasting glucagon to insulin ratio was significantly lower in patients with metabolic syndrome (14.0 ± 9.7 vs. 17.3 ± 10.3, p < 0.05). The fasting glucagon to insulin ratio was significantly lowered as the number of metabolic syndrome components increased. In hierarchical logistic regression analysis, the fasting glucagon to insulin ratio significantly contributed to metabolic syndrome even after adjusting for other covariates. The fasting glucagon to insulin ratio is inversely associated with metabolic syndrome in patients with type 2 diabetes. This suggests that glucagon-targeted therapeutics may reduce cardiovascular risk by improving metabolic syndrome. |
format | Online Article Text |
id | pubmed-10531641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105316412023-09-28 Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes Bang, Jisun Lee, Sang Ah Koh, Gwanpyo Yoo, Soyeon J Clin Med Article There is a growing interest in the role of glucagon in type 2 diabetes mellitus (T2DM). Glucagon and insulin regulate glucose and lipid metabolism. Metabolic syndrome is an important risk factor for cardiovascular disease in patients with T2DM. We investigated the association between glucagon to insulin ratio and metabolic syndrome in patients with T2DM. This is a cross-sectional study involving 317 people with type 2 diabetes. Glucagon and insulin levels were measured in a fasted state and 30 min after ingesting a standard mixed meal. The Criteria of the International Diabetes Federation defined metabolic syndrome. Two hundred nineteen (69%) of the subjects had metabolic syndrome. The fasting glucagon to insulin ratio was significantly lower in patients with metabolic syndrome (14.0 ± 9.7 vs. 17.3 ± 10.3, p < 0.05). The fasting glucagon to insulin ratio was significantly lowered as the number of metabolic syndrome components increased. In hierarchical logistic regression analysis, the fasting glucagon to insulin ratio significantly contributed to metabolic syndrome even after adjusting for other covariates. The fasting glucagon to insulin ratio is inversely associated with metabolic syndrome in patients with type 2 diabetes. This suggests that glucagon-targeted therapeutics may reduce cardiovascular risk by improving metabolic syndrome. MDPI 2023-09-06 /pmc/articles/PMC10531641/ /pubmed/37762748 http://dx.doi.org/10.3390/jcm12185806 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bang, Jisun Lee, Sang Ah Koh, Gwanpyo Yoo, Soyeon Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title | Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title_full | Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title_fullStr | Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title_full_unstemmed | Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title_short | Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes |
title_sort | association of glucagon to insulin ratio and metabolic syndrome in patients with type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531641/ https://www.ncbi.nlm.nih.gov/pubmed/37762748 http://dx.doi.org/10.3390/jcm12185806 |
work_keys_str_mv | AT bangjisun associationofglucagontoinsulinratioandmetabolicsyndromeinpatientswithtype2diabetes AT leesangah associationofglucagontoinsulinratioandmetabolicsyndromeinpatientswithtype2diabetes AT kohgwanpyo associationofglucagontoinsulinratioandmetabolicsyndromeinpatientswithtype2diabetes AT yoosoyeon associationofglucagontoinsulinratioandmetabolicsyndromeinpatientswithtype2diabetes |